CombiGene: Warrants commence trading
In connection with the completed preferential rights issue in CombiGene AB (publ)
(”CombiGene” or ”the Company”), subscribers were allotted warrants of series 2018/2019. Trading in warrants on Spotlight Stock Market will commence on 31 October 2018 and the final day of trading in these warrants will be 26 September 2019.
Subscription warrants of series 2018/2019 entitle the holder to subscribe for one new share in the company at a subscription price of 70% of the volume-weighted average price of the company’s share during the period from 15 August 2019 up to and including 28 August 2019. The subscription price will not be less than SEK 2.00 per share or exceed SEK 2.50 per share. Subscription for shares in the company, with subscription rights of series 2018/2019, may take place during the period 1 September 2019 through 30 September 2019. Full utilization of all warrants of series 2018/2019 will increase the company’s share capital by at most SEK 687,913,00 via issuance of at most 6,879,130 shares. The company’s share capital will then amount to SEK 5,847,260.60 distributed over 58,472,606 shares.